These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33093920)
21. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055 [TBL] [Abstract][Full Text] [Related]
22. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4. Niu J; Li Z; Li F Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397 [TBL] [Abstract][Full Text] [Related]
24. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling. Song X; Wang Z; Liang H; Zhang W; Ye Y; Li H; Hu Y; Zhang Y; Weng H; Lu J; Wang X; Li M; Liu Y; Gu J Int J Biol Sci; 2017; 13(6):782-793. PubMed ID: 28656003 [TBL] [Abstract][Full Text] [Related]
25. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394 [TBL] [Abstract][Full Text] [Related]
26. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772 [TBL] [Abstract][Full Text] [Related]
27. Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation. Cao X; Yang Y; Zhou W; Wang Y; Wang X; Ge X; Wang F; Zhou F; Deng X; Miao L BMC Cancer; 2023 May; 23(1):471. PubMed ID: 37221457 [TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. Yang L; Gao Q; Wu X; Feng F; Xu K J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773 [TBL] [Abstract][Full Text] [Related]
29. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells. Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509 [TBL] [Abstract][Full Text] [Related]
30. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis. Li ML; Wang XF; Tan ZJ; Dong P; Gu J; Lu JH; Wu XS; Zhang L; Ding QC; Wu WG; Rao LH; Mu JS; Yang JH; Weng H; Ding Q; Zhang WJ; Chen L; Liu YB Int J Immunopathol Pharmacol; 2012; 25(4):955-65. PubMed ID: 23298486 [TBL] [Abstract][Full Text] [Related]
31. CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. Huang M; Zhong F; Chen M; Hong L; Chen W; Abudukeremu X; She F; Chen Y Front Oncol; 2023; 13():1156177. PubMed ID: 37274251 [TBL] [Abstract][Full Text] [Related]
32. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer. Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077 [TBL] [Abstract][Full Text] [Related]
33. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation. Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855 [TBL] [Abstract][Full Text] [Related]
34. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. Qin Y; Wang J; Gong W; Zhang M; Tang Z; Zhang J; Quan Z Oncol Rep; 2014 Jun; 31(6):2635-43. PubMed ID: 24756644 [TBL] [Abstract][Full Text] [Related]
35. Melatonin inhibits gallbladder cancer cell migration and invasion via ERK-mediated induction of epithelial-to-mesenchymal transition. Tang H; Shi X; Zhu P; Guo W; Li J; Yan B; Zhang S Oncol Lett; 2021 Aug; 22(2):609. PubMed ID: 34188711 [TBL] [Abstract][Full Text] [Related]
36. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680 [TBL] [Abstract][Full Text] [Related]
38. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545 [TBL] [Abstract][Full Text] [Related]
39. Ursolic acid isolated from Chen H; Wu X; Duan Y; Zhi D; Zou M; Zhao Z; Zhang X; Yang X; Zhang J Oncol Lett; 2019 Aug; 18(2):1467-1474. PubMed ID: 31423212 [TBL] [Abstract][Full Text] [Related]
40. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]